🇺🇸 Metclopramide in United States

FDA authorised Metclopramide on 7 February 1979

Marketing authorisations

FDA — authorised 7 February 1979

  • Application: NDA017862
  • Marketing authorisation holder: HIKMA
  • Local brand name: REGLAN
  • Indication: INJECTABLE — INJECTION
  • Status: approved

Read official source →

FDA — authorised 30 December 1980

  • Application: NDA017854
  • Marketing authorisation holder: ANI PHARMS
  • Local brand name: REGLAN
  • Indication: TABLET — ORAL
  • Status: approved

Read official source →

Other Other approved in United States

Frequently asked questions

Is Metclopramide approved in United States?

Yes. FDA authorised it on 7 February 1979; FDA authorised it on 30 December 1980.

Who is the marketing authorisation holder for Metclopramide in United States?

HIKMA holds the US marketing authorisation.